- Home
- ZYBT
as 02-21-2025 4:00pm EST
Stocks
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.
| Founded: | 2004 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 201.4M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 33.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.06 | EPS Growth: | -53.70 |
| 52 Week Low/High: | $3.70 - $6.10 | Next Earning Date: | 01-01-0001 |
| Revenue: | $26,111,272 | Revenue Growth: | -25.23% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ZHENGYE BIOTECHNOLOGY HLDG LTD News
ZYBT Breaking Stock News: Dive into ZYBT Ticker-Specific Updates for Smart Investing
Compare ZYBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.